Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Aqua-{tris-[(1H-benzimidazol-2-yl-?N)meth-yl]amine}-zinc 5-(dimethyl-amino)-naphthalene-1-sulfonate perchlorate 2.5-hydrate.

ABSTRACT: In the title compound, [Zn(C(24)H(21)N(7))(H(2)O)](C(12)H(12)NO(3)S)(ClO(4))·2.5H(2)O, the Zn(II) ion is in a distorted trigonal-bipyramidal coordination geometry. In the crystal, N-H?O and O-H?O hydrogen bonds connect the components into a two-dimensional network parallel to (001). In addition, there are weak C-H?O hydrogen bonds.

SUBMITTER: Xiao ZA

PROVIDER: S-EPMC3238661 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Aqua-{tris-[(1H-benzimidazol-2-yl-κN)meth-yl]amine}-zinc 5-(dimethyl-amino)-naphthalene-1-sulfonate perchlorate 2.5-hydrate.

Xiao Zuo-An ZA Jiang Ting-Ting TT

Acta crystallographica. Section E, Structure reports online 20111112 Pt 12

In the title compound, [Zn(C(24)H(21)N(7))(H(2)O)](C(12)H(12)NO(3)S)(ClO(4))·2.5H(2)O, the Zn(II) ion is in a distorted trigonal-bipyramidal coordination geometry. In the crystal, N-H⋯O and O-H⋯O hydrogen bonds connect the components into a two-dimensional network parallel to (001). In addition, there are weak C-H⋯O hydrogen bonds. ...[more]

PMID: 22199552

Similar Datasets

Aqua(dimethylformamide){tris[(1-methyl-1H-benzimidazol-2-yl)methyl]amine}nickel(II) dipicrate.

Project description:In the title complex, [Ni(C(27)H(27)N(7))(C(3)H(7)NO)(H(2)O)](C(6)H(2)N(3)O(7))(2), the Ni(II) ion is coordinated in a slightly distorted octa-hedral coordination evironment by an NiN(4)O(2) ligand set. The tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine ligand is in a tetra-dentate mode while a coordinated water molecule and a dimethyl-formamide ligand complete the coordination. In the crystal structure, inter-molecular O-H?O hydrogen bonds link the cation and one of the pictrate anions into four-component centrosymmetric clusters.

| S-EPMC3007476 | biostudies-literature

Salicylato[tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (τ parameter = 0.84), with approximate mol-ecular C(3) symmetry. One dimethyl-formamide mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis.

| S-EPMC2915077 | biostudies-literature

(Dicyanamido)[tris-(2-pyridylmeth-yl)amine]zinc(II) perchlorate.

Project description:In the title complex, [Zn(C(2)N(3))(C(18)H(18)N(4))]ClO(4), the Zn(II) ion has a slightly distorted trigonal-bipyramidal ZnN(5) coordination geometry. The crystal structure is stabilized by weak inter-molecular C-H?O and C-H?N hydrogen bonds. In addition, there are relatively close contacts between the O atoms of the perchlorate anion and symmetry-related pyridine rings [O?Cg = 3.179?(3) and 3.236?(3)?Å, where Cg is the centroid of a pyridine ring], and between the terminal N atom of the dicyanamide ligand and pyridine rings [N?Cg = 3.381?(4)-3.761?(3)?Å]. The central N atom of the dicyanamide ligand is disordered over two sites in an approximately 0.6:0.4 ratio.

| S-EPMC2960752 | biostudies-literature

Acrylato[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]cobalt(II) perchlorate-dimethyl-formamide-methanol (2/2/3).

Project description:In the title complex, [Co(C(3)H(3)O(2))(C(27)H(27)N(7))]ClO(4)·C(3)H(7)NO·1.5CH(4)O, the Co(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.90 and 0.10. In addition, the solvent hemimethanol mol-ecule is disordered over two positions with equal occupancies. The crystal structure is stabilized by weak intermolecular O-H⋯O hydrogen bonds.

| S-EPMC2959638 | biostudies-literature

(Dimethyl-formamide)(2-methyl-propen-oato)[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]-manganese(II) perchlorate dimethyl-formamide solvate.

Project description:In the title complex, [Mn(C(4)H(5)O(2))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is seven-coordinated in a distorted monocapped trigonal-prismatic geometry formed by a tetra-dentate tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine mol-ecule, a bidentate 2-methacrylate anion and a dimethyl-formamide mol-ecule. The methyl groups of the coordinated dimethyl-formamide mol-ecule and the perchlorate anions are disordered over two positions with occupancy factors of 0.640 (8) and 0.360 (8).

| S-EPMC2983334 | biostudies-literature

Tris(1H-benzimidazol-3-ium-2-ylmeth-yl)amine tris-(2,4,6-trinitro-phenolate) acetonitrile disolvate.

Project description:In the cation of the title salt, C(24)H(24)N(7) (3+)·3C(6)H(2)N(3)O(7) (-)·2C(2)H(3)N, the three benzimidazolium ring systems are oriented to each other at dihedral angles of 10.42 (7), 23.98 (7) and 22.17 (7)°. In the crystal, the cation links to the adjacent picrate anions via N-H⋯O hydrogen bonds; one of independent acetonitrile solvent mol-ecules is also linked to the cation via an N-H⋯N hydrogen bond.

| S-EPMC3379477 | biostudies-literature

Acrylato[tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate-dimethyl-formamide-methanol (1/1/1.5) at 153 (2) K.

Project description:In the title complex, [Zn(C(3)H(3)O(2))(C(27)H(27)N(7))](ClO(4))·C(3)H(7)NO·1.5CH(4)O, the Zn(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.84 and 0.16. In addition, a methanol solvent mol-ecule is disordered over two sites with equal occupancies. In the crystal structure, the full-occupancy methanol is linked to a dimethyl-formamide mol-ecule by an inter-molecular O-H⋯O hydrogen bond.

| S-EPMC2960207 | biostudies-literature

Dichlorido[tris-(benzimidazol-2-ylmeth-yl)amine]-indium(III) chloride ethanol solvate dihydrate.

Project description:In the title complex, [InCl(2)(C(24)H(21)N(7))]Cl·C(2)H(5)OH·2H(2)O, the In(III) ion is coordinated by four N atoms from the tris-(benz-imidazol-2-ylmeth-yl)amine (NTB) ligand and two Cl atoms in a distorted octa-hedral environment. In the crystal structure, inter-molecular N-H?O, O-H?O, O-H?Cl and weak C-H?Cl hydrogen bonds connect the cations, anions and solvent mol-ecules into a three-dimensional network. The ethanol solvent mol-ecule is disordered over two sites with refined occupancies of 0.54?(2) and 0.46?(2).

| S-EPMC3007265 | biostudies-literature

(2-Hydroxy-benzoato-κO)[tris-(1-methyl-benzimidazol-2-ylmethyl-κN)amine-κN]cobalt(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Co(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Co(II) ion is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The perchlorate ion is disordered over two sites with equal occupancy. One dimethyl-formamide solvent mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis. There is an intra-molecular O-H⋯O hydrogen bond in the cation.

| S-EPMC2959500 | biostudies-literature

Crystal structure of aqua-tris-(isonicotinamide-?N)bis-(thio-cyanato-?N)cobalt(II) 2.5-hydrate.

Project description:The asymmetric unit of the title compound, [Co(NCS)2(C6H6N2O)3(H2O)]·2.5H2O, comprises one CoII cation, three isonicotinamide ligands, two thio-cyanate anions, one aqua ligand and two water solvent mol-ecules in general positions, as well as one water solvent mol-ecule that is located on a twofold rotation axis. The CoII cations are octa-hedrally coordinated by two terminally N-bonded thio-cyanate anions, one water mol-ecule and three isonicotinamide ligands, each coordinating via the pyridine N atom. The discrete complexes are linked by inter-molecular O-H?O, N-H?O and N-H?S hydrogen bonding into a three-dimensional network that contains cavities in which the solvent water mol-ecules are located. The latter are linked by further O-H?O hydrogen bonds to the network. There are additional short contacts present in the crystal, indicative of weak C-H?S, C-H?O and C-H?N inter-actions.

| S-EPMC5120703 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data